glp 1 updates There has been a drug safety update from Medicines and Healthcare products Regulatory Agency (MHRA) for healthcare professionals 6-months off GLP-1 update :

Due to limited safety data on glutathione supplementation during pregnancy, many healthcare professionals recommend avoiding non-essential supplements unless specifically advised by a doctor

Any preexisting malignancy should be inactive and its treatment complete prior to instituting therapy with tesamorelin

Doctors should look at genetic tests and each patients situation to find the right dose

The incretin effect is significantly blunted in type 2 diabetes mellitus (T2DM) and restoration of this incretin signalling could be effective as a treatment strategy for diabetes, obesity and metabolic dysfunctions [5, 6]

la Fleur and Serlie, 2014)